These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC, PROTECT Investigators and Committees. N Engl J Med; 2010 Oct 07; 363(15):1419-28. PubMed ID: 20925544 [Abstract] [Full Text] [Related]
6. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials. Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R, Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca–Heart Failure (GISSI-HF) Investigators. Circulation; 2012 Jan 17; 125(2):280-8. PubMed ID: 22139751 [Abstract] [Full Text] [Related]
7. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, Cotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JG, O'Connor CM, Givertz MM. J Am Coll Cardiol; 2011 May 10; 57(19):1899-907. PubMed ID: 21545947 [Abstract] [Full Text] [Related]
8. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function. Weatherley BD, Cotter G, Dittrich HC, DeLucca P, Mansoor GA, Bloomfield DM, Ponikowski P, O'Connor CM, Metra M, Massie BM, PROTECT Steering Committee, Investigators, and Coordinators. J Card Fail; 2010 Jan 10; 16(1):25-35. PubMed ID: 20123315 [Abstract] [Full Text] [Related]
9. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, Greenberg BH, Filippatos G, Davison BA, Cotter G, Prescott MF, Hua TA, Lopez-Pintado S, Severin T, Metra M. Eur J Heart Fail; 2015 Dec 10; 17(12):1262-70. PubMed ID: 26333655 [Abstract] [Full Text] [Related]
10. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study. Demir M, Kanadasi M, Akpinar O, Dönmez Y, Avkarogullari M, Alhan C, Inal T, San M, Usal A, Demirtas M. Angiology; 2007 Dec 10; 58(5):603-9. PubMed ID: 18024945 [Abstract] [Full Text] [Related]
11. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP, Tognoni G, Cohn JN, Val-HeFT Investigators. Circulation; 2007 Sep 11; 116(11):1242-9. PubMed ID: 17698733 [Abstract] [Full Text] [Related]
12. Do cardiac troponins provide prognostic insight in hemodialysis patients? Choy JB, Armstrong PW, Ulan RA, Campbell PM, Gourishankar S, Prosser CI, Tymchak WJ. Can J Cardiol; 2003 Jul 11; 19(8):907-11. PubMed ID: 12876611 [Abstract] [Full Text] [Related]
13. Cardiac troponin and outcome in acute heart failure. Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH, ADHERE Investigators. N Engl J Med; 2008 May 15; 358(20):2117-26. PubMed ID: 18480204 [Abstract] [Full Text] [Related]
14. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM, Protect Steering Committee, Investigators, and Coordinators. J Card Fail; 2008 Oct 15; 14(8):631-40. PubMed ID: 18926433 [Abstract] [Full Text] [Related]
16. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Perna ER, Macin SM, Canella JP, Augier N, Stival JL, Cialzeta JR, Pitzus AE, Garcia EH, Obregón R, Brizuela M, Barbagelata A. Circulation; 2004 Oct 19; 110(16):2376-82. PubMed ID: 15477403 [Abstract] [Full Text] [Related]
17. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Tentzeris I, Jarai R, Farhan S, Perkmann T, Schwarz MA, Jakl G, Wojta J, Huber K. Eur J Heart Fail; 2011 Jul 19; 13(7):726-33. PubMed ID: 21616953 [Abstract] [Full Text] [Related]